NCT06257433 InformationSeekingMesolimbicEngagementStudy2
| NCT ID | NCT06257433 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Temple University |
| Condition | Motivation |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2023-10-24 |
| Primary Completion | 2026-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2023-10-24 with a primary completion date of 2026-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Participants will complete a treasure task during neuroimaging where they have to learn which keys open a treasure chest, and then they are tested on the contents of the treasure chest.
Eligibility Criteria
Inclusion Criteria: * 20/40 far acuity (either corrected or uncorrected) * In good medical health Exclusion Criteria: * History of head injury * History of illness with Central Nervous Systems implications * On Medications that Affect blood flow response and alertness * Consumption of smoking and/or coffee 30 minutes prior to laboratory testing * Placement of a device contraindicated for magnetic resonance imaging including cardia pacemaker, aneurysm clip, cochlear implants, pregnancy, intra-uterine device, shrapnel, metal fragments in the eyes, neurostimulators * Weight \> 250lbs * Claustrophobia
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06257433 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying Motivation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06257433 currently recruiting?
Yes, NCT06257433 is actively recruiting participants. Contact the research team at vishnu.murty@temple.edu for enrollment information.
Where is the NCT06257433 trial being conducted?
This trial is being conducted at Philadelphia, United States.
Who is sponsoring the NCT06257433 clinical trial?
NCT06257433 is sponsored by Temple University. The trial plans to enroll 80 participants.